Conference LibraryGated
Interius BioTherapeutics · in vivo CAR-T (acquired by Kite/Gilead)
Interius BioTherapeutics · in vivo CAR-T 公司 · lentiviral delivery · 2025 被 Kite (Gilead 子公司) 以 $350M 收购(per OPORD-002 verify priority)。 对 SunVax 的对标:lentiviral 而非 LNP · 不同 modality 但同 in vivo cell engineering 大方向。
- Type
- company
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- B
- category
- in_vivo_car_t_lentiviral
- status
- draft
- instance_tag
- sunvax-antibody-2025
- platform_tech
- lentiviral · in vivo CAR-T
- acquisitions
- [object Object]
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.